Opportunity Information: Apply for CDC RFA GH20 2027
Apply for CDC RFA GH20 2027
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Support Government of the Kingdom of Eswatini (GKoE) to Provide Comprehensive, Quality Assured Care, Treatment and Prevention HIV/TB Services to Achieve and Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Jan 07, 2020.
- Applicants must submit their applications by Mar 07, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity is a CDC cooperative agreement under PEPFAR focused on helping the Government of the Kingdom of Eswatini strengthen and sustain HIV and TB epidemic control by improving the quality, reach, and consistency of services delivered through the Ministry of Health. The work is concentrated in two administrative regions, Manzini and Lubombo, and is designed to reinforce routine facility-based care while also extending services and messaging into surrounding communities so more people are reached, linked to care, and retained in treatment over time.
The program is centered on comprehensive HIV service delivery with an emphasis on quality assurance across the entire clinical pathway. That includes HIV testing services and stronger linkages to treatment for those who test positive, with added attention to treatment retention, patient follow-up, and tracking systems that reduce loss to follow-up. It also includes cervical cancer screening for women living with HIV, recognizing the elevated risk in this population and the importance of integrating prevention and early detection into HIV care platforms.
Laboratory strengthening is a major component, particularly viral load testing, which is essential for monitoring treatment effectiveness and achieving viral suppression at scale. The opportunity also covers broader HIV-related laboratory diagnostics needed to support clinical decision-making and timely patient management. Alongside HIV services, the award supports integrated TB prevention, diagnosis, and treatment for people living with HIV, as well as HIV prevention, diagnosis, and treatment services for people with TB. This bidirectional integration is meant to reduce missed opportunities and improve outcomes for co-infected patients.
The opportunity explicitly includes services for priority and vulnerable groups, including pediatric and adolescent HIV/TB programming. It also supports prevention of mother-to-child transmission (PMTCT) services and structured follow-up for HIV-exposed infants, ensuring early infant diagnosis, continuity of care, and rapid initiation of treatment when needed. Additional prevention interventions include voluntary medical male circumcision and pre-exposure prophylaxis, both of which are key PEPFAR-supported strategies for reducing new HIV infections and sustaining epidemic control.
Implementation is expected to occur through direct site-level support to Ministry of Health facilities, paired with community-facing activities. The community component is intended to reinforce demand creation, communication, prevention, and treatment literacy, and to connect populations to services in ways that improve uptake and long-term engagement. A capacity-building focus runs throughout the award: recipients are expected to strengthen facility managers and local leadership so Eswatini national HIV guidelines and programs are implemented consistently and with fidelity, rather than relying indefinitely on external technical direction.
The opportunity also anticipates support for human resources, particularly for positions not covered under the formal government establishment, where staffing gaps could otherwise limit service delivery. In addition, monitoring and evaluation is a required pillar of the work, including strengthening routine data systems and improving data use at supported facilities so performance can be measured, gaps can be identified quickly, and program improvements can be made based on evidence rather than assumptions.
From an administrative standpoint, the opportunity is identified as CDC RFA GH20-2027, offered by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CGH), with CFDA number 93.067. It is a discretionary funding opportunity using a cooperative agreement mechanism, indicating substantial involvement by CDC in programmatic collaboration and oversight. Eligibility is listed as unrestricted, meaning a wide range of entity types may apply, subject to any additional eligibility clarifications in the full announcement. CDC anticipated making two awards. For budgeting, the notice states that the Year 1 award ceiling is listed as 0 (none), while the approximate total fiscal year funding for Year 1 was anticipated at $15,000,000, contingent on the availability of funds. The opportunity was created January 7, 2020, with an original closing date of March 7, 2020, and applications were due electronically by 11:59 p.m. Eastern Time on the deadline date.
Frequently Asked Questions (FAQs)
1) What is this funding opportunity?
This is a CDC cooperative agreement under PEPFAR focused on helping the Government of the Kingdom of Eswatini strengthen and sustain HIV and TB epidemic control by improving the quality, reach, and consistency of services delivered through the Ministry of Health.
2) Which agency is offering the opportunity?
The opportunity is offered by the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), specifically CDC CGH.
3) What is the funding mechanism and what does it imply?
The mechanism is a cooperative agreement. This indicates substantial involvement by CDC in programmatic collaboration and oversight during implementation.
4) What is the opportunity number and CFDA number?
The opportunity is identified as CDC RFA GH20-2027, with CFDA number 93.067.
5) What is the overall goal of the program?
The program aims to strengthen and sustain HIV and TB epidemic control in Eswatini by improving service quality and consistency, reinforcing routine facility-based care, and extending services and messaging into surrounding communities to improve reach, linkage to care, and long-term retention in treatment.
6) Where will the work be implemented?
The work is concentrated in two administrative regions in Eswatini: Manzini and Lubombo.
7) What types of HIV service delivery activities are emphasized?
The program centers on comprehensive HIV service delivery with an emphasis on quality assurance across the full clinical pathway, including HIV testing services, stronger linkage to treatment for those testing positive, and attention to retention, follow-up, and tracking systems to reduce loss to follow-up.
8) Does the opportunity include cervical cancer screening?
Yes. Cervical cancer screening for women living with HIV is included, reflecting the elevated risk in this population and the importance of integrating prevention and early detection into HIV care platforms.
9) What laboratory components are included?
Laboratory strengthening is a major component, particularly viral load testing to monitor treatment effectiveness and support viral suppression at scale. The opportunity also includes broader HIV-related laboratory diagnostics needed for clinical decision-making and timely patient management.
10) How does the opportunity address TB in relation to HIV?
The award supports integrated TB prevention, diagnosis, and treatment for people living with HIV, and also supports HIV prevention, diagnosis, and treatment services for people with TB. This bidirectional integration is intended to reduce missed opportunities and improve outcomes for co-infected patients.
11) Are priority or vulnerable populations included in the scope?
Yes. The opportunity explicitly includes services for priority and vulnerable groups, including pediatric and adolescent HIV/TB programming.
12) Does the program support PMTCT and care for HIV-exposed infants?
Yes. It supports prevention of mother-to-child transmission (PMTCT) services and structured follow-up for HIV-exposed infants, including early infant diagnosis, continuity of care, and rapid initiation of treatment when needed.
13) What HIV prevention interventions are included?
Additional prevention interventions include voluntary medical male circumcision and pre-exposure prophylaxis (PrEP), both described as key PEPFAR-supported strategies for reducing new HIV infections and sustaining epidemic control.
14) What is the expected implementation approach at the facility level?
Implementation is expected to occur through direct site-level support to Ministry of Health facilities.
15) What community-based activities are expected?
The community component is intended to reinforce demand creation, communication, prevention and treatment literacy, and to connect populations to services in ways that improve uptake and long-term engagement.
16) Is capacity building part of the award?
Yes. A capacity-building focus runs throughout the award, with expectations to strengthen facility managers and local leadership so national HIV guidelines and programs are implemented consistently and with fidelity, rather than relying indefinitely on external technical direction.
17) Does the opportunity allow support for human resources?
Yes. The opportunity anticipates support for human resources, particularly for positions not covered under the formal government establishment where staffing gaps could otherwise limit service delivery.
18) What monitoring and evaluation (M&E) requirements are highlighted?
Monitoring and evaluation is a required pillar of the work, including strengthening routine data systems and improving data use at supported facilities so performance can be measured, gaps can be identified quickly, and program improvements can be made based on evidence.
19) Who is eligible to apply?
Eligibility is listed as unrestricted, meaning a wide range of entity types may apply, subject to any additional eligibility clarifications in the full announcement.
20) How many awards did CDC anticipate making?
CDC anticipated making two awards.
21) What was the anticipated total funding for Year 1?
The approximate total fiscal year funding anticipated for Year 1 was $15,000,000, contingent on the availability of funds.
22) What was the Year 1 award ceiling?
The notice states the Year 1 award ceiling was listed as 0 (none).
23) When was the opportunity created and what was the original closing date?
The opportunity was created on January 7, 2020, and had an original closing date of March 7, 2020.
24) How and when were applications due?
Applications were due electronically by 11:59 p.m. Eastern Time on the deadline date.
25) What does the program mean by improving retention and reducing loss to follow-up?
Based on the description, this includes stronger patient follow-up and tracking systems intended to keep patients engaged in care over time and reduce the number of patients who stop attending services after diagnosis or treatment initiation.
Browse more business programs for Epidemic Control
Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH
Browse more opportunities from the same category: Health
Next opportunity: Internet Freedom: Advancing and Promoting Peer-to-Peer Communications Technologies
Previous opportunity: Support for the Republican AIDS Center of the Republic of Tajikistan to Maintain and Promote High-Quality HIV Services to Achieve Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH20 2027
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH20 2027) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening the Delivery of Quality HIV/TB Laboratory Services at all Levels Including Quality Management Systems, Equipment, and Laboratory Network Optimization for Efficient Patient Management in the Kingdom of Eswatini under PEPFAR Apply for CDC RFA GH20 2026 Funding Number: CDC RFA GH20 2026 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Coordination and Strengthening of the Kingdom of Eswatini Ministry of Health's HIV and TB Programs under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2028 Funding Number: CDC RFA GH20 2028 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Service Area Competition Apply for HRSA 20 100 Funding Number: HRSA 20 100 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening of the Kingdom of Eswatini's Voluntary Medical Male Circumcision (VMMC) Program under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2029 Funding Number: CDC RFA GH20 2029 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Expanding Access to Quality Laboratory Service (EQUALS) in the Kingdom of Lesotho under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2044 Funding Number: CDC RFA GH20 2044 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Enhancing the Government of India's Capacity through Technical Assistance to India's National AIDS Control Organization (NACO) to Strengthen the Prevention to Treatment Cascade for People Living with HIV, Including Key Populations, under PE Apply for CDC RFA GH20 2038 Funding Number: CDC RFA GH20 2038 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Pilot Centers for Precision Disease Modeling (U54)(Clinical Trials Not Allowed) Apply for PAR 20 085 Funding Number: PAR 20 085 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,250,000 |
| Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2059 Funding Number: CDC RFA GH20 2059 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Accelerating Lesotho's Progress to Epidemic Control Through Health System Strengthening and Delivery of Comprehensive HIV/TB Care, Treatment and Prevention Services under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2045 Funding Number: CDC RFA GH20 2045 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Accelerating and Sustaining HIV Epidemic Control and Related Diseases in Western and West-Nile Regions in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2065 Funding Number: CDC RFA GH20 2065 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Namibia Project for Information System Strengthening, Continuous Quality Improvement and Enhanced Surveillance to Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2060 Funding Number: CDC RFA GH20 2060 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Building Capacity within the Government of Tanzania to Oversee Laboratory, Strengthen Scientific Oversight, Monitor Evidence-based HIV Interventions, and Conduct Geo-spatial Analysis under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2064 Funding Number: CDC RFA GH20 2064 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in Georgia Apply for RFA GH 20 004 Funding Number: RFA GH 20 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $10,000,000 |
| Strengthening the Government of Uganda's Capacity for Regionally Centered and District Implemented HIV and TB Programming through Health Information Systems, Case Based Surveillance, Monitoring, Evaluation and Quality Improvement Support under P Apply for CDC RFA GH20 2066 Funding Number: CDC RFA GH20 2066 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Civil Society Organizations' Capacity and Coordination for Accelerated HIV Epidemic Control in Uganda through Supporting Implementation of Comprehensive HIV/AIDS Prevention and Treatment for Key Populations (KP) under PEPFAR Apply for CDC RFA GH20 2068 Funding Number: CDC RFA GH20 2068 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Innovative, Comprehensive, Cost-effective and Locally Sustainable Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2082 Funding Number: CDC RFA GH20 2082 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Engagement of FBOs and CBOs/PNFPs to Support and Sustain HIV Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2069 Funding Number: CDC RFA GH20 2069 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Partnering with Ho Chi Minh City Pasteur Institute (PI) for Continued Capacity Strengthening to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH20 2070 Funding Number: CDC RFA GH20 2070 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Conducting Public Health Research in South America Apply for RFA GH 20 005 Funding Number: RFA GH 20 005 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $5,000,000 |
| National Organizations of State and Local Officials: Health Care Payment and Financing Apply for HRSA 20 093 Funding Number: HRSA 20 093 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,065,416 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH20 2027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.